Gut Hormones as Potential Therapeutic Targets or Biomarkers of Response in Depression: The Case of Motilin
Recent research has identified the gut–brain axis as a key mechanistic pathway and potential therapeutic target in depression. In this paper, the potential role of gut hormones as potential treatments or predictors of response in depression is examined, with specific reference to the peptide hormone...
Main Author: | Ravi Philip Rajkumar |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2021-08-01
|
Series: | Life |
Subjects: | |
Online Access: | https://www.mdpi.com/2075-1729/11/9/892 |
Similar Items
-
Characterization of rat intestinal immunoreactive motilin (IR-M)
by: Vogel, Lee
Published: (2010) -
Effects of Motilin Receptor Agonists and Ghrelin in Human <i>motilin receptor</i> Transgenic Mice
by: Tomoe Kawamura, et al.
Published: (2019-03-01) -
Motilin Comparative Study: Structure, Distribution, Receptors, and Gastrointestinal Motility
by: Takio Kitazawa, et al.
Published: (2021-08-01) -
Regulation of Gastrointestinal Motility by Motilin and Ghrelin in Vertebrates
by: Takio Kitazawa, et al.
Published: (2019-05-01) -
Systematic Review of Gut Microbiota and Major Depression
by: Stephanie G. Cheung, et al.
Published: (2019-02-01)